[go: up one dir, main page]

SV2002000339A - ACETILSALICILIC ACID SOLUTIONS REF. READ 33813-SV - Google Patents

ACETILSALICILIC ACID SOLUTIONS REF. READ 33813-SV

Info

Publication number
SV2002000339A
SV2002000339A SV2001000339A SV2001000339A SV2002000339A SV 2002000339 A SV2002000339 A SV 2002000339A SV 2001000339 A SV2001000339 A SV 2001000339A SV 2001000339 A SV2001000339 A SV 2001000339A SV 2002000339 A SV2002000339 A SV 2002000339A
Authority
SV
El Salvador
Prior art keywords
ref
read
acid solutions
acetilsalicilic
acetilsalicilic acid
Prior art date
Application number
SV2001000339A
Other languages
Spanish (es)
Inventor
Wolfgang Wiehl
Dietmar Bahn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV2002000339A publication Critical patent/SV2002000339A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SOLUCIONES DE AAS ADECUADAS PARA EL TRATAMIENTO TOPICO DEL DOLOR.ADEQUATE AAS SOLUTIONS FOR THE TOPICAL TREATMENT OF PAIN.

SV2001000339A 2000-03-07 2001-03-07 ACETILSALICILIC ACID SOLUTIONS REF. READ 33813-SV SV2002000339A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (en) 2000-03-07 2000-03-07 Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster

Publications (1)

Publication Number Publication Date
SV2002000339A true SV2002000339A (en) 2002-06-07

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000339A SV2002000339A (en) 2000-03-07 2001-03-07 ACETILSALICILIC ACID SOLUTIONS REF. READ 33813-SV

Country Status (9)

Country Link
EP (1) EP1263441A2 (en)
AR (1) AR028237A1 (en)
AU (1) AU2001272099A1 (en)
DE (1) DE10011032A1 (en)
GT (1) GT200100035A (en)
HN (1) HN2001000039A (en)
PE (1) PE20030207A1 (en)
SV (1) SV2002000339A (en)
WO (1) WO2001066115A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
WO2007125492A2 (en) * 2006-05-02 2007-11-08 Pfeinsmith S.A. (Pty) Ltd Acidic composition
JP7335232B2 (en) * 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ，インコーポレーテッド Intravial Deposits of Stable, Sterile and Crystalline O-Acetylsalicylic Acid (Aspirin)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
WO1995019759A1 (en) * 1994-01-24 1995-07-27 The Procter & Gamble Company Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
EP1263441A2 (en) 2002-12-11
AR028237A1 (en) 2003-04-30
AU2001272099A1 (en) 2001-09-17
GT200100035A (en) 2001-12-18
HN2001000039A (en) 2001-07-09
WO2001066115A3 (en) 2002-02-14
WO2001066115A2 (en) 2001-09-13
DE10011032A1 (en) 2001-09-13
PE20030207A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
ES2092113T3 (en) FLUOROALCOXYBENCILAMINE DERIVATIVES OF HETEROCICLES CONTAINING NITROGEN.
CY1119029T1 (en) THERAPEUTIC TREATMENT OF COMPOSITIONAL LABORATORY TREATMENTS WITH A RAPAMYKIN PRODUCT
DK2052714T3 (en) Topical gel feeding system for the treatment of skin disorders
UY26249A1 (en) SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES LAW 17164 ART. 127
AR024944A1 (en) AMIDAS OF CARBOXILIC ACIDS, MEDICATIONS CONTAINING THESE COMPOUNDS, THEIR USE AND THEIR PREPARATION
DE60035639D1 (en) hydroxydiphenyl
CY1105482T1 (en) USE OF AZITHROMYCIN IN THE TOPICAL TREATMENT OF EYE INFECTIONS
ES2178761T3 (en) USE OF 1-HYDROXY-2-PYRIDONAS FOR THE TREATMENT OF CUTANEOUS INFECTIONS.
BR0209541A (en) Use of 2-phenyl-substituted imidazotriazinones
FI20000635A0 (en) Use of COMT inhibitors as an analgesic
DE60127131D1 (en) TRICYCLIC IMIDAZOPYRIDINE
SV1996000008A (en) USE OF AMENAS OF FENILCICLOHEXILCARBOXILICOS ACID
SV2002000339A (en) ACETILSALICILIC ACID SOLUTIONS REF. READ 33813-SV
IT1306165B1 (en) USE OF INHIBITORS OF THE SUBSTANCE P FOR THE TREATMENT OF DENOCARCINOMAS.
EA200200948A1 (en) TREATMENT OF PSORIASIS
ES2134184T3 (en) USE OF ETISTERONE FOR THE TOPICAL TREATMENT OF ACNE OR ANDROGENETIC ALOPECIA.
AR008860A1 (en) USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SEBORRHEAL DERMATITIS
EA200200853A1 (en) APPLICATION OF 2-METHYL THIAZOLIDINE-3,3-DICARBONIC ACID (2-MTDK) AND / OR ITS PHYSIOLOGICAL COMPATIBLE SALTS FOR THE TREATMENT AND / OR CANCER PREVENTION
DE60129600D1 (en) PLEUROMUTILINE DERIVATIVES WITH ANTIMICROBIAL EFFECT
UY26498A1 (en) SUBSTITUTED PYRROLES
NO20005548D0 (en) Mykobakterieinhibitorer
IT1320192B1 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PSORIASIS.
UY27394A1 (en) ORDERS WITH ANTI-ANGIOGÉNA ACTIVITY.
GB0312566D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
AR021694A1 (en) 7-ARIL-6- (Z) HEPTATRIENOIC ACID RETINAMIDS

Legal Events

Date Code Title Description
FD Lapse